JP2022545253A5 - - Google Patents
Info
- Publication number
- JP2022545253A5 JP2022545253A5 JP2022511190A JP2022511190A JP2022545253A5 JP 2022545253 A5 JP2022545253 A5 JP 2022545253A5 JP 2022511190 A JP2022511190 A JP 2022511190A JP 2022511190 A JP2022511190 A JP 2022511190A JP 2022545253 A5 JP2022545253 A5 JP 2022545253A5
- Authority
- JP
- Japan
- Prior art keywords
- asparaginase
- conjugate
- optionally
- use according
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1912020.3 | 2019-08-21 | ||
| GBGB1912020.3A GB201912020D0 (en) | 2019-08-21 | 2019-08-21 | Therapeutic Conjugate |
| PCT/GB2020/052022 WO2021032997A1 (en) | 2019-08-21 | 2020-08-21 | Therapeutic conjugate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545253A JP2022545253A (ja) | 2022-10-26 |
| JP2022545253A5 true JP2022545253A5 (https=) | 2023-08-29 |
Family
ID=68099464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022511190A Pending JP2022545253A (ja) | 2019-08-21 | 2020-08-21 | 治療用コンジュゲート |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220331411A1 (https=) |
| EP (2) | EP4017525A1 (https=) |
| JP (1) | JP2022545253A (https=) |
| KR (1) | KR20220050934A (https=) |
| CN (1) | CN114450029A (https=) |
| AU (1) | AU2020332081A1 (https=) |
| BR (1) | BR112022003126A2 (https=) |
| CA (1) | CA3151718A1 (https=) |
| GB (1) | GB201912020D0 (https=) |
| IL (1) | IL290747A (https=) |
| WO (1) | WO2021032997A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3156066A1 (en) | 2019-10-25 | 2021-04-29 | Mi Rim Choi | Recombinant l-asparaginase |
| WO2022211829A1 (en) * | 2021-03-30 | 2022-10-06 | Jazz Pharmaceuticals Ireland Ltd. | Dosing of recombinant l-asparaginase |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS57077B2 (sr) * | 2009-07-06 | 2023-06-30 | Jazz Pharmaceuticals Ii Sas | Pegilovana l-asparaginaza |
| WO2011003633A1 (en) * | 2009-07-06 | 2011-01-13 | Alize Pharma Ii | Pegylated l-asparaginase |
| EP3701036A4 (en) * | 2017-10-27 | 2021-09-01 | Pfenex Inc. | PROCESS FOR PRODUCING ASPARAGINASE OF E. COLI |
| JP7784804B2 (ja) * | 2017-10-27 | 2025-12-12 | フェネックス インク． | 組み換えｅｒｗｉｎｉａアスパラギナーゼの製造のための方法 |
| CA3240356A1 (en) * | 2017-11-30 | 2019-06-06 | Jazz Pharmaceuticals Ireland Ltd. | Methods of treatment with asparaginase |
-
2019
- 2019-08-21 GB GBGB1912020.3A patent/GB201912020D0/en not_active Ceased
-
2020
- 2020-08-21 KR KR1020227009029A patent/KR20220050934A/ko not_active Withdrawn
- 2020-08-21 JP JP2022511190A patent/JP2022545253A/ja active Pending
- 2020-08-21 EP EP20765071.4A patent/EP4017525A1/en active Pending
- 2020-08-21 WO PCT/GB2020/052022 patent/WO2021032997A1/en not_active Ceased
- 2020-08-21 AU AU2020332081A patent/AU2020332081A1/en not_active Abandoned
- 2020-08-21 US US17/635,942 patent/US20220331411A1/en not_active Abandoned
- 2020-08-21 CA CA3151718A patent/CA3151718A1/en active Pending
- 2020-08-21 EP EP24152887.6A patent/EP4368251A3/en not_active Withdrawn
- 2020-08-21 CN CN202080065507.9A patent/CN114450029A/zh active Pending
- 2020-08-21 BR BR112022003126A patent/BR112022003126A2/pt unknown
-
2022
- 2022-02-20 IL IL290747A patent/IL290747A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7217700B2 (ja) | 安定化非タンパク質クロストリジウム毒素組成物 | |
| Ishida et al. | Anti-polyethyleneglycol antibody response to PEGylated substances | |
| HUP0201530A2 (en) | Use of therapeutic agent comprising a botulinum neurotoxin | |
| US20070292404A1 (en) | Antimicrobial polymer conjugates | |
| JP2022545253A5 (https=) | ||
| ZA202213371B (en) | Compositions and methods useful for the prevention and/or treatment of disease in mammals | |
| JP2024137952A (ja) | クロストリジウム毒素－ヒアルロン酸組成物 | |
| US7452533B2 (en) | Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol | |
| US7332307B2 (en) | Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense system | |
| US12370242B2 (en) | Formulations of pegylated arginine deiminase | |
| JP7085482B2 (ja) | スタフィロコッカス感染症のための凍結乾燥製剤を製造する方法 | |
| CA2189990A1 (en) | Compositions and treatment for multiple sclerosis | |
| RU2005101076A (ru) | Фармацевтический препарат и способ лечения злокачественных опухолей у человека с помощью аргининовой депривации | |
| WO1997020579A2 (en) | Novel compounds and use | |
| US7063837B2 (en) | Syrup composition containing phage associated lytic enzymes | |
| MXPA05011304A (es) | Composiciones a base de peptidos de alfa timosina para el tratamiento y prevencion de infecciones virales respiratorias. | |
| JP6530768B2 (ja) | サイトカイン−キトサンバイオコンジュゲート及びその使用方法 | |
| EP0699078B1 (en) | A method to prevent side effects and insensitivity to the therapeutic uses of toxins | |
| US8877183B2 (en) | Methods for treatment of ocular diseases | |
| JP2002523521A (ja) | ワクチン抗原としてのスーパーオキシドジスムターゼ | |
| RU2022107082A (ru) | Терапевтический конъюгат | |
| JPWO2019176729A1 (ja) | 新規バクテリオファージおよび細菌性眼内炎治療剤 | |
| CN1777438A (zh) | 用α胸腺肽治疗或预防呼吸病毒的感染 | |
| EP0420743A1 (fr) | Vaccin protecteur contre l'hémophilose porcine | |
| CN107693796B (zh) | Peg定点修饰的门冬酰胺酶注射剂 |